GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gala Pharmaceutical Inc (OTCPK:GLPH) » Definitions » Effective Interest Rate on Debt %

Gala Pharmaceutical (Gala Pharmaceutical) Effective Interest Rate on Debt % : 76.07% (As of May. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Gala Pharmaceutical Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Gala Pharmaceutical's annualized positive value of Interest Expense for the quarter that ended in May. 2019 was $0.23 Mil. Gala Pharmaceutical's average total debt for the quarter that ended in May. 2019 was $0.31 Mil. Therefore, Gala Pharmaceutical's annualized Effective Interest Rate on Debt % for the quarter that ended in May. 2019 was 76.07%.

Gala Pharmaceutical Effective Interest Rate on Debt % Historical Data

The historical data trend for Gala Pharmaceutical's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gala Pharmaceutical Effective Interest Rate on Debt % Chart

Gala Pharmaceutical Annual Data
Trend Nov11 Nov12 Nov13 Nov14 Nov15 Nov16 Nov17 Nov18
Effective Interest Rate on Debt %
Get a 7-Day Free Trial - - 2.58 153.22 20.90

Gala Pharmaceutical Quarterly Data
Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.45 27.08 23.49 37.24 76.07

Competitive Comparison of Gala Pharmaceutical's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Gala Pharmaceutical's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gala Pharmaceutical's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gala Pharmaceutical's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Gala Pharmaceutical's Effective Interest Rate on Debt % falls into.


Gala Pharmaceutical Effective Interest Rate on Debt % Calculation

Gala Pharmaceutical's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Nov. 2018 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Nov. 2017 )+Total Debt  (A: Nov. 2018 ))/ count )
=-1  *  -0.074/( (0.416+0.292)/ 2 )
=-1  *  -0.074/0.354
=20.90 %

where

Total Debt  (A: Nov. 2017 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 0.416
=0.416

Total Debt  (A: Nov. 2018 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 0.292
=0.292

Gala Pharmaceutical's annualized Effective Interest Rate on Debt % for the quarter that ended in May. 2019 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Feb. 2019 )+Total Debt  (Q: May. 2019 ))/ count )
=-1  *  -0.232/( (0.288+0.322)/ 2 )
=-1  *  -0.232/0.305
=76.07 %

where

Total Debt  (Q: Feb. 2019 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 0.288
=0.288

Total Debt  (Q: May. 2019 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 0.322
=0.322

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (May. 2019) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Gala Pharmaceutical  (OTCPK:GLPH) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Gala Pharmaceutical Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Gala Pharmaceutical's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gala Pharmaceutical (Gala Pharmaceutical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gala Pharmaceutical Inc (OTCPK:GLPH) » Definitions » Effective Interest Rate on Debt %
Comparable Companies
LSE:PYC PRTX PPCB BTHE TSXV:IBT XCNQ:DOSE TSXV:APC RSPI XCNQ:LILY OBMP ASX:MEB XSAT:CLINE B AMBS WAR:RDG ASX:ACL TNTY TSXV:MFS VODG GOVX ASX:RAC
Traded in Other Exchanges
N/A
Address
18881 Von Karman Avenue, Suite 1440, Irvine, CA, USA, 92612
Website
https://www.galapharmaceuticals.com
Gala Pharmaceutical Inc is a United States-based company engaged in the hemp and cannabidiol (CBD) industry. It is focused on the development, research, and commercialization of products derived from the hemp and cannabis plant. It is focused on CBD flavored thin-film strip which is an advanced method of providing CBD for the dietary supplement. The services offered by the company are the development of cannabinoid-based health and wellness products; development of medical grade compounds; licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry. The group earns revenue from the sale of products related to hemp and CBD, including modified electronic cigarettes and vape pens.